Detecting and explaining postpartum depression in real-time with generative artificial intelligence

Among the many challenges mothers undergo after childbirth, postpartum depression ( ppd) is a severe condition that significantly impacts their mental and physical well-being. Consequently, the rapid detection of ppd and their associated risk factors is critical for in-time assessment and intervention through specialized prevention procedures. Accordingly, this work addresses the need to help practitioners make decisions with the latest technological advancements to enable real-time screening and treatment recommendations. Mainly, our work contributes to an intelligent ppd screening system that combines Natural Language Processing, Machine Learning ( ml), and Large Language Models ( llm s) towards an affordable, real-time, and non-invasive free speech analysis. Moreover, it addresses the black box problem since the predictions are described to the end users thanks to the combination of llm s with interpretable ml models ( i.e., tree-based algorithms) using feature importance and natural language. The results obtained are 90 % on ppd detection for all evaluation metrics, outperforming the competing solutions in the literature. Ultimately, our solution contributes to the rapid detection of ppd and their associated risk factors, critical for in-time and proper assessment and intervention. Introduction Depression is a global public health concern that affects more than 150 million people, being more prevalent in women (Labaka et al., 2018; Moreira et al., 2019). Among the many challenges mothers undergo after childbirth, postpartum depression ( ppd) is a severe condition that usually requires medical intervention (Falana & Carrington, 2019). Mainly, ppd is a common non-psychotic mental disorder during the first year after childbirth that can lead to severe complications in the women's health (Abadiga, 2019). Current data indicates that between 10 % to 15 % of mothers worldwide are affected with ppd yearly (Fatima et al., 2019; Liu et al., 2023). Moreover, only 20% of the target population is diagnosed or even treated promptly (Mazumder & Baruah, 2021).